Rating History for Intercept Pharmaceuticals (ICPT) by B.Riley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/26/2023 | Chad L. Mabry | Downgrade | Neutral (Buy) |
N/A (N/A) |
10.44 (19.00) |
81.99% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/26/2023 | Chad L. Mabry | Downgrade | Neutral (Buy) |
N/A (N/A) |
10.44 (19.00) |
81.99% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
